Endogenous prostaglandins regulate spontaneous contractile activity of uterine strips isolated from non-pregnant pigs

Prostaglandins and Other Lipid Mediators

Volumn 81, Issue 3-4, 2006, Pages 93-105

  Cao, Jinshan ^a,b   Kitazawa, Takio ^a   Takehana, Kazushige ^a   Taneike, Tetsuro ^a  

^a RAKUNO GAKUEN UNIVERSITY   (Japan)

^b INNER MONGOLIA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Cyclooxygenase; Porcine uterus; Prostaglandins; Prostanoid receptors; Spontaneous contraction

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOXAZOLE DERIVATIVE; PIPERAZINE DERIVATIVE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTANOID RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MECHANICAL STIMULATION; MYOMETRIUM; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; SWINE; UTERUS CONTRACTILITY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROST; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOHISTOCHEMISTRY; MYOMETRIUM; PREGNANCY; PROSTAGLANDINS; PROSTAGLANDINS F; PYRAZOLES; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PROSTAGLANDIN E; SWINE; UTERINE CONTRACTION;

EID: 33750528750     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2006.08.003     Document Type: Article

References (45)

1. Kosaka T., Miyata A., Ihara H., et al. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem 221 (1994) 889
2. Slater D.M., Dennes W.J., Campa J.S., Poston L., and Bennett P.R. Expression of cyclo-oxygenase types-1 and -2 in human myometrium throughout pregnancy. Mol Hum Reprod 5 (1999) 880
3. Schuster V.L. Prostaglandin transport. Prostaglandins Other Lipid Mediat 68/69 (2002) 633
4. Tsuboi K., Sugimoto Y., and Ichikawa A. Prostanoid receptor subtypes. Prostaglandins Other Lipid Mediat 68/69 (2002) 535
5. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79 (1999) 1193
6. Keirse M.J.N.C. Endogenous prostaglandins in human parturition. In: Keirse M.J.N.C., Anderson A.B.M., and Bernebrock G.J. (Eds). Human praturition, uterine contractility (1979), University Press, Leiden 101
7. Chan W.Y. Uterine and placental prostaglandins and their modulation of oxytocin sensitivity and contractility in the parturient uterus. Biol Reprod 29 (1983) 680
8. Challis J.R.G., Olson D.M., and Parturition. In: Knobil E., and Neill J. (Eds). The physiology of reproduction (1988), Random Press, New York 2177
9. Romero R., Munoz H., Gomez R., et al. Increase in prostaglandin bioavailability precedes the onset of human parturition. Prostaglandins Leukot Essent Fatty Acids 54 (1996) 187
10. Loftin C.D., Trivedi D.B., and Langenbach R. Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus. J Clin Invest 110 (2002) 549
11. Peri K.G., Quiniou C., Hou X., et al. THG113: a novel selective FP antagonist that delays preterm labor. Semin Perinatol 26 (2002) 389
12. Sugimoto Y., Yamasaki A., Segi E., et al. Failure of parturition in mice lacking the prostaglandin F receptor. Science 277 (1997) 681
13. Davis B.J., Lennard D.E., Lee C.A., et al. Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1beta. Endocrinology 140 (1999) 2685
14. Crankshaw D.J., and Dyal R. Effects of some naturally occurring prostanoids and some cyclooxygenase inhibitors on the contractility of the human lower uterine segment in vitro. Can J Physiol Pharmacol 72 (1994) 870
15. Garfield R.E., Hayashi R.H., and Harper M.J. In vitro studies on the control of human myometrial gap junctions. Int J Gynaecol Obstet 25 (1987) 241
16. Liggins G.C. Initiation of labour. Biol Neonate 55 (1989) 366
17. Sawdy R., Slater D., Fisk N., Edmonds D.K., and Bennett P. Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet 350 (1997) 265
18. Fang L., Chatterjee S., Dong Y.L., Gangula P.R., and Yallampalli C. Immunohistochemical localization of constitutive and inducible cyclo-oxygenases in rat uterus during the oestrous cycle and pregnancy. Histochem J 30 (1998) 383
19. Cao J., Shayibuzhati M., Tajima T., Kitazawa T., and Taneike T. In vitro pharmacological characterization of the prostanoid receptor population in the non-pregnant porcine myometrium. Eur J Pharmacol 442 (2002) 115
20. Cao J., Wakatsuki A., Yoshida M., Kitazawa T., and Taneike T. Thromboxane A2 (TP) receptor in the non-pregnant porcine myometrium and its role in regulation of spontaneous contractile activity. Eur J Pharmacol 485 (2004) 317
21. Crankshaw D.J. Pharmacological techniques for the in vitro study of the uterus. J Pharmacol Toxicol Meth 45 (2001) 123
22. McDonald L.E. Female reproductive system. In: McDonald L.E. (Ed). Veterinary endocrinology and reproduction. 2nd ed. (1975), Lea & Febiger, Philadelphia 247
23. Taneike T., Miyazaki H., Nakamura H., and Ohga A. Autonomic innervation of the circular and longitudinal layers in swine myometrium. Biol Reprod 45 (1991) 831
24. Kitazawa T., Maezono Y., and Taneike T. The mechanisms of alpha(2)-adrenoceptor agonist-induced contraction in longitudinal muscle of the porcine uterus. Eur J Pharmacol 390 (2000) 185
25. Lowry O.H., Rosebrough N.J., Farr A., and Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 193 (1951) 265
26. Smith C.J., Zhang Y., Koboldt C.M., et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 95 (1998) 13313
27. Ochi T., Motoyama Y., and Goto T. The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models. Eur J Pharmacol 391 (2000) 49
28. Habeeb A.G., Rao P.N.P., and Knaus E.E. Design and syntheses of diarylisoxazoles: novel inhibitors of cyclooxygenase-2 (COX-2) with analgesic-antiinflammatory activity. Drug Dev Res 51 (2001) 273
29. Cao J., Yosida M., Kitazawa T., and Taneike T. Uterine region-dependent differences in responsiveness to prostaglandins in the non-pregnant porcine myometrium. Prostaglandins Other Lipid Mediat 75 (2005) 105
30. Korita D., Itoh H., Sagawa N., et al. 17beta-Estradiol up-regulates prostacyclin production in cultured human uterine myometrial cells via augmentation of both cyclooxygenase-1 and prostacyclin synthase expression. J Soc Gynecol Investig 11 (2004) 457
31. Moore S.D., Brodt-Eppley J., Cornelison L.M., Burk S.E., Slater D.M., and Myatt L. Expression of prostaglandin H synthase isoforms in human myometrium at parturition. Am J Obstet Gynecol 180 (1999) 103
32. Zuo J., Lei Z.M., Rao C.V., Pietrantoni M., and Cook V.D. Differential cyclooxygenase-1 and -2 gene expression in human myometria from preterm and term deliveries. J Clin Endocrinol Metab 79 (1994) 894
33. Myatt L., Langdon G., and Brockman D.E. Identification and changes in concentrations of prostaglandin H synthase (PGHS) isoforms in rat myometrium at parturition. Prostaglandins 48 (1994) 285
34. Dong Y.L., Gangula P.R., Fang L., and Yallampalli C. Differential expression of cyclooxygenase-1 and -2 proteins in rat uterus and cervix during the estrous cycle, pregnancy, labor and in myometrial cells. Prostaglandins 52 (1996) 13
35. Wu W.X., Ma X.H., Zhang Q., Buchwalder L., and Nathanielsz P.W. Regulation of prostaglandin endoperoxide H synthase 1 and 2 by estradiol and progesterone in nonpregnant ovine myometrium and endometrium in vivo. Endocrinology 138 (1997) 4005
36. Charpigny G., Reinaud P., Tamby J.P., et al. Expression of cyclooxygenase-1 and -2 in ovine endometrium during the estrous cycle and early pregnancy. Endocrinology 138 (1997) 2163
37. Gupta D.K., Sato T.A., Keelan J.A., Marvin K.W., and Mitchell M.D. Expression of prostaglandin H synthase-1 and -2 in murine intrauterine and gestational tissues from mid pregnancy until term. Prostaglandins Other Lipid Mediat 66 (2001) 17
38. Tsuboi K., Sugimoto Y., Iwane A., Yamamoto K., Yamamoto S., and Ichikawa A. Uterine expression of prostaglandin H2 synthase in late pregnancy and during parturition in prostaglandin F receptor-deficient mice. Endocrinology 141 (2000) 315
39. Lee D.S., Yanagimoto Ueta Y., Xuan X., et al. Expression patterns of the implantation-associated genes in the uterus during the estrous cycle in mice. J Reprod Dev 51 (2005) 787
40. Arosh J.A., Banu S.K., Kimmins S., Chapdelaine P., Maclaren L.A., and Fortier M.A. Effect of interferon-tau on prostaglandin biosynthesis, transport, and signaling at the time of maternal recognition of pregnancy in cattle: evidence of polycrine actions of prostaglandin E2. Endocrinology 145 (2004) 5280
41. Giannoulias D., Patel F.A., Holloway A.C., Lye S.J., Tai H.H., and Challis J.R. Differential changes in 15-hydroxyprostaglandin dehydrogenase and prostaglandin H synthase (types I and II) in human pregnant myometrium. J Clin Endocrinol Metab 87 (2002) 1345
42. Hurd W.W., Gibbs S.G., Ventolini G., Horowitz G.M., and Guy S.R. Shortening increases spontaneous contractility in myometrium from pregnant women at term. Am J Obstet Gynecol 192 (2005) 1295
43. Young R.C., and Zhang P. Inhibition of in vitro contractions of human myometrium by mibefradil, a T-type calcium channel blocker: support for a model using excitation-contraction coupling, and autocrine and paracrine signaling mechanisms. J Soc Gynecol Investig 12 (2005) e7
44. Slattery M.M., Friel A.M., Healy D.G., and Morrison J.J. Uterine relaxant effects of cyclooxygenase-2 inhibitors in vitro. Obstet Gynecol 98 (2001) 563
45. Garza J., Clayton N., Kaviani A., Maher T.J., and Fauza D. In situ inhibition of uterine activity by indomethacin: possible relevance to preterm labor prevention after fetal surgery. J Pediatr Surg 39 (2004) 1173